Status:
COMPLETED
Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy
Lead Sponsor:
Institut de Cancérologie de la Loire
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the feasibility and the effectiveness of a patient education program on patients' adherence to adjuvant hormone therapy (anti-estrogen or aromatase inhibitors)...
Eligibility Criteria
Inclusion
- Aged over 18
- History of breast cancer
- Medical prescription for an adjuvant hormonal treatment (anti-estrogens and / or aromatase inhibitors) as monotherapy or in combination with other treatments
- Affiliated to a social security scheme
Exclusion
- Refusal to participate, patient protected by guardianship.
- Patient unable to understand the study or unable to follow the education sessions.
- Patient with documented cognitive or psychiatric history.
- Geographical remotness (more than 100 Kms).
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
352 Patients enrolled
Trial Details
Trial ID
NCT02300675
Start Date
May 1 2014
End Date
August 1 2017
Last Update
September 14 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Lyon Sud
Pierre-Bénite, France, 69495
2
Hôpital Privé de la Loire
Saint-Etienne, France
3
Institut de Cancérologie de la Loire
Saint-Priest-en-Jarez, France, 42270